ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BTAI BioXcel Therapeutics Inc

3.08
-0.09 (-2.84%)
Feb 23 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,348,463
Bid Price 3.07
Ask Price 3.15
News -
Day High 3.27

Low
1.91

52 Week Range

High
32.87

Day Low 3.05
Share Name Share Symbol Market Stock Type
BioXcel Therapeutics Inc BTAI NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.09 -2.84% 3.08 19:00:00
Open Price Low Price High Price Close Price Previous Close
3.16 3.05 3.27 3.07 3.17
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
9,250 1,348,463 US$ 3.14 US$ 4,238,954 - 1.91 - 32.87
Last Trade Type Quantity Price Currency
18:53:06 1 US$ 3.14 USD

BioXcel Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
90.16M 29.27M - 375k -165.76M -5.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

BioXcel Therapeutics News

Date Time Source News Article
2/14/202406:00Edgar (US Regulatory)Form 8-K - Current report
2/13/202408:00GlobeNewswire Inc.BioXcel Therapeutics Announces Termination of Proposed..
2/12/202411:45Edgar (US Regulatory)Form 8-K - Current report
2/12/202406:14GlobeNewswire Inc.BioXcel Therapeutics Receives FDA Fast Track Designation for..
2/08/202416:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
2/08/202415:53Edgar (US Regulatory)Form 8-K - Current report
2/08/202415:01GlobeNewswire Inc.BioXcel Therapeutics Announces Proposed Public Offering
2/08/202406:08Edgar (US Regulatory)Form 8-K - Current report
2/06/202406:00GlobeNewswire Inc.BioXcel Therapeutics Announces Completion of Patient..
2/05/202406:00GlobeNewswire Inc.BioXcel Therapeutics Announces USPTO’s Allowance of Patent..
1/22/202423:15Edgar (US Regulatory)Form EFFECT - Notice of Effectiveness
1/12/202415:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BTAI Message Board. Create One! See More Posts on BTAI Message Board See More Message Board Posts

Historical BTAI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.663.823.003.392,225,119-0.58-15.85%
1 Month3.274.171.912.823,590,907-0.19-5.81%
3 Months3.804.171.912.881,601,136-0.72-18.95%
6 Months4.005.61991.913.292,359,679-0.92-23.00%
1 Year29.1332.871.916.792,059,099-26.05-89.43%
3 Years53.7660.361.9111.43950,560-50.68-94.27%
5 Years8.3474.891.9116.98711,493-5.26-63.07%

BioXcel Therapeutics Description

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com